Keyphrases
Amphiregulin
100%
Cancer Cell Growth
9%
Cancer Cell Survival
9%
Cancer Cells
9%
Carcinoma Cells
100%
Cell Growth
18%
Cell Survival
18%
Chromosomal Translocation
9%
Clinical Outcomes
9%
CREB Transcription Factor
9%
CRTC1-MAML2
100%
Downstream Target Genes
9%
Effective Treatment
9%
Epidermal Growth Factor Receptor
9%
Epidermal Growth Factor Receptor Ligands
9%
Epidermal Growth Factor Receptor Signaling
100%
Functional Studies
9%
Fusion Gene
9%
Fusion Oncogene
18%
Gene Expression Analysis
9%
Genetic Modification
9%
Head-and-neck
9%
Highly Heterogeneous
9%
Highly Sensitive
9%
Interference Modulation
9%
Mucoepidermoid Carcinoma
100%
Neck Malignancy
9%
Oncogene
9%
Oncoprotein
9%
Pharmacological Modulation
9%
Receptor-targeted Therapy
9%
Recurring
9%
RNA Interference
9%
Salivary Gland Tumor
18%
Target Pathways
9%
Therapeutic Targeting
9%
Tumor Growth
9%
Xenograft Model
9%
Medicine and Dentistry
Amphiregulin
100%
Cancer
9%
Cancer Cell
9%
Cancer Growth
9%
Carcinoma Cell
100%
Cell Growth
18%
Cell Survival
27%
Chromosome Translocation
9%
Epidermal Growth Factor Receptor
100%
Fusion Gene
9%
Gene Expression Profiling
9%
Gene Fusion
18%
Gene Mutation
9%
In Vitro
18%
Mucoepidermoid Carcinoma
100%
Neck
9%
Oncogene
9%
Oncoprotein
9%
RNAI
9%
Salivary Gland Neoplasm
18%
Targeted Therapy
9%
Transcription Factors
9%
Tumor Progression
9%
Upregulation
9%
Xenograft
9%
Biochemistry, Genetics and Molecular Biology
Amphiregulin
100%
Cancer Cell
22%
Cell Growth
33%
Cell Survival
33%
Chromosomal Translocation
11%
CREB
11%
CRTC1
100%
Epidermal Growth Factor Receptor
100%
Fusion Gene
11%
Gene Expression Profiling
11%
Gene Fusion
22%
Gene Mutation
11%
Oncogene
11%
RNAI
11%
Transcription Factors
11%
Tumor Progression
11%
Upregulation
11%
Pharmacology, Toxicology and Pharmaceutical Science
Amphiregulin
100%
Cancer Growth
9%
Chromosome Translocation
9%
Epidermal Growth Factor Receptor
100%
Malignant Neoplasm
9%
Mucoepidermoid Tumor
100%
Oncoprotein
9%
Salivary Gland Tumor
18%
Transcription Factors
9%
Tumor Growth
9%